# CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry

> **NCT00643617** · NA · COMPLETED · sponsor: **Accuray Incorporated** · enrollment: 307 (actual)

## Conditions studied

- Prostate Cancer
- Prostatic Cancer
- Prostatic Neoplasms
- Prostate Neoplasms
- Cancer of the Prostate

## Interventions

- **RADIATION:** CyberKnife Stereotactic Radiosurgery - Low Risk
- **RADIATION:** CyberKnife Stereotactic Radiosurgery - Intermediate Risk

## Key facts

- **NCT ID:** NCT00643617
- **Lead sponsor:** Accuray Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10-22
- **Primary completion:** 2022-04-07
- **Final completion:** 2022-04-07
- **Target enrollment:** 307 (ACTUAL)
- **Last updated:** 2023-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00643617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00643617, "CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00643617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*